BITAMMON

Medicinal product

(Invented) name

BITAMMON

Active substance (s)

Sultamicilinas

Strength

375 mg

Pharmaceutical form

plėvele dengtos tabletės

Route (s) of administration

vartoti per burną

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

J01CR04, Sultamicillin

Marketing authorisation holder

UAB Niromed, Lietuva

Date of authorisation

2022-11-29

Date of renewal

Documents

1779_BITAMMON 375mg_pl_deng_tab_PZPL_2022-11-29.docx

Stage

Registruotas

Controlled?

No

Controlled substance type

Legal basis

Procedure number

Marketing authorisation procedure

Lygiagretus importas

Qualitative and quantitative composition

Tabletėje yra	1 vnt.
Sultamicilinas	375 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
109927	96034	1096034	lizdinė plokštelė	N14		Receptinis	LT/L/22/1779/001	Netiekiama	2024-12-16	2025-06-30	No	-	-	Download

Stadijos

Data	Stadija
2022-11-29	Registruotas